Jens Renstrup's most recent trade in SpringWorks Therapeutics Inc was a trade of 48,600 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Jan. 7, 2021.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
SpringWorks Therapeutics Inc | Jens Renstrup | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2021 | 48,600 | 48,600 | - | - | Stock Option (Right to Buy) | |
SpringWorks Therapeutics Inc | Jens Renstrup | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2021 | 6,075 | 250,499 (0%) | 0% | 0 | Common Stock |